SlideShare uma empresa Scribd logo
1 de 128
acute renal failure … from basics to the latest advances Joel M. Topf, MD Clinical Nephrologist http://pbfluids.com
the house moment
Dr. Haas invented the first dialysis machine designed for humans and in 1928 he treated 6 patients.  All of them died.
In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine.  In 1943 he dialyzed his first patient, a young man with acute nephritis.  In 1945, a 67-year-old woman in uremic coma presented to Dr Kolff.                 Regained consciousness after 11 hours of hemodialysis.         Dr. Haas
[object Object],[object Object]
 
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
Same rise in creatinine. Same diagnosis: acute renal failure. Two completely different diseases. Two women. Same age. Same race.
definition of acute renal failure  ,[object Object],35   definitions
[object Object],biochemical  definitions
[object Object],[object Object],[object Object],[object Object],event driven definitions
 
 
R  isk I  njury F  ailure L  oss of function E  nd-Stage Renal disease rifle criteria for  stratifying arf
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
R  isk :  Inc Cr 50-100% or U.O. < 0.5 mL/kg/hr for > 6 hrs I  njury : Inc Cr 100-200% or U.O. < 0.5 mL/kg/hr > 12 hrs F  ailure : Inc Cr > 200% or > 4 mg/dL or U.O. < 0.3 mL/kg/hr > 24 hrs or anuria for more than 12 hours L  oss of function : Need for dialysis for more than 4 weeks E  nd-Stage Renal disease  : Need for dialysis for more than 3 months
nice criteria. do they work? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Uchino S, Bellomo R, Goldsmith D. Crit Care Med 2006 Vol 34 1913-1917.
Hospital Mortality >3x BL Cr Cr > 4
nice criteria. do they work in the icu? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Hoste E, Clermont G, Kersten A. Crit Care 2006 Vol 310
 
when Hoste looked at markers of severity of illness excluding the renal system: No survival difference between the 4 groups:  •  Lack of renal failure • Risk • Injury • Failure
RIFLE is dependent on creatinine. creatine is a functional marker of organ damage Functional markers: old  and busted
biomarkers are foot prints of actual organ damage Biomarkers,  new hotness
functional versus biomarkers Functional Marker Biomarker Liver damage Hypoalbuminemia Coagulopathy SGOT SGPT GGT
functional versus biomarkers Functional Marker Biomarker Liver damage Hypoalbuminemia Coagulopathy SGOT SGPT GGT Heart damage Hypotension Arrhythmia Troponin I Troponin T CK-MB
functional versus biomarkers Functional Marker Biomarker Liver damage Hypoalbuminemia Coagulopathy SGOT SGPT GGT Heart damage Hypotension Arrhythmia Troponin I Troponin T CK-MB Kidney damage Creatinine BUN Cystatin C KIM-1 NGAL
creatinine as a lagging indicator ,[object Object],[object Object],[object Object]
<0.5 0.4 0.2 0.1 0.3 0.5 0.7 0.9 Creatinine falls Creatinine rises Delta Creatinine (mg/dL)
candidates for a renal troponin:
[object Object],[object Object],[object Object],candidates for a renal troponin: kidney injury molecule-1 (kim-1) 2.00 0.34 0.13 0.69 Han WH, Bailly V, Abichandani. Kidney Int 2002 62, 237–244. Liangos O, Han WK, Wald R. Abstract J Am Soc Nephrol 16: 318A, 2005.
candidates for a renal troponin: kidney injury molecule-1 (kim-1) ,[object Object],[object Object],[object Object],Time starts at aorta cross clamp. Cr rose to 2.1. Han WH, Bailly V, Abichandani. Kidney Int 2002 62, 237–244. Liangos O, Han WK, Wald R. Abstract J Am Soc Nephrol 16: 318A, 2005.
urinary neutrophil gelatinase-associated lipocalin (ngal) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Mishra J, Ma Q, Prada A. J Am Soc Nephrol 2003; 14: 2534-43. Wagener G, Jan M, K M. Anesthesia 2006; 105: 485-91.
 
 
 
differential diagnosis
etiologies of arf ,[object Object],[object Object],[object Object],[object Object],[object Object]
Hou SH, Bushinsky DA, Wish JB. Am J Med 1983; 74: 243-8. Nash K, Hafeez A, Hou S. Am J Kidney Dis. 2002; 39: 930-6. Kaufman J, Dhakal M, Patel B, Et al. Am J Kidney Dis 1991; 17: 191-8.
Hou SH, Bushinsky DA, Wish JB. Am J Med 1983; 74: 243-8. Nash K, Hafeez A, Hou S. Am J Kidney Dis. 2002; 39: 930-6. Kaufman J, Dhakal M, Patel B, Et al. Am J Kidney Dis 1991; 17: 191-8.
N=103 N=256 N=389 Pascual J, Liano F. J Am Geriatr Soc 1998, 46: 1-5.
hospital acquired acute renal failure
hospital acquired acute renal failure
 
 
Pre-renal azotemia No BP, no pee pee
Pre-renal ARF ,[object Object],no bp, no pee pee RPF a u t o r e g u l a t i o n GFR
differentiation of prerenal from intrinsic renal disease ,[object Object],[object Object],[object Object]
 
Excreted Na Filtered Na Fractional excretion of sodium:
Excreted Na   = Urine Na x Urine Volume Calculating the Numerator
Filtered Na  = Serum Na x GFR Calculating the Denominator GFR =  Urine Cr x Urine Volume   Serum Cr Filtered Na  =  Serum Na x UrCr x UrVol   Serum Cr
Urine Na  x  Urine Volume Serum Na x UrCr x Urine Volume Serum Cr FENa = Excreted Na Filtered Na FENa = Urine Na Serum Na x UrCr   Serum Cr FENa = Urine Na x Serum Cr Serum Na x UrCr FENa =
FENa the easy way ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Sr Na Sr Cr x  Ur Na x  Ur Cr FENa  =
FeNa. what is it good for? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Miller, Schrier, Et al. Annals Int Med, 1978 Vol 89. p 47-50 Pre-renal azotemia ATN (oliguric and non-oliguric) FENa < 1 27 4 FENa > 1 3 51 Pre-renal azotemia ATN (oliguric and non-oliguric) FENa > 1 3 51 FENa < 1 27 4
Low FENa, Not pre-renal ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],FENa False Positive
FeNa false negatives ,[object Object],[object Object],High FENa, but pre-renal
[object Object],[object Object],[object Object],[object Object],Low fractional excretion of sodium in acute renal failure Role of timing of the test and ischemia
fractional excretion of urea ,[object Object],[object Object],[object Object],[object Object],Kaplan, Kohn. American J Nephrol, 1992; 12: 49-54. Sr Na Sr Cr x  Ur Na x  Ur Cr FENa  = Sr Urea Sr Cr x  Ur Urea x  Ur Cr FEurea  =
 
 
FEurea in the differential diagnosis of atn ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Carvounis, Sabeeha, Nisar, Et al. Kidney Int, 2002 Vol 62. p 2223-2229
FENa FEUrea
therapy Renal replacement therapy Furosemide Dopamine Fenoldapam hANP (Anaritide)
renal replacement therapy
Dialysate Conventional Dialysis Diffusive Clearance 136 5.8 108 17 67 3.8 145 2 110 35 0 0
80 mmol K 5.8 mmol/L = 13.8 liters Isolated Ultrafiltration: CHF Solutions Minimal clearance 136 5.8 108 17 67 3.8 136 5.8 108 17 67 3.8
Ultrafilter 3+  liters/hour Replace all ultrafiltrate with sterile fluid at ideal plasma concentrations CVVH Convective clearance 136 5.8 108 17 67 3.8 140 2 108 30 0 0 140 4 108 30 0 0
Post-filter replacement fluid CVVH Convective clearance
Pre-filter replacement fluid CVVH Convective clearance
CVVHDF Convective and Diffusive
high dose dialysis survival Severity of illness (CCARF Score) High dose Low dose
Ronco’s landmark dialysis dose study ,[object Object],[object Object],[object Object],[object Object]
20 mL/kg/hr 35 mL/kg/hr 45 mL/kg/hr Ronco C, Bellomo R, Hormea P, Et al. Lancet 2000; 355: 26-30.
Schiffl: daily dialysis versus three days/wk dialysis ,[object Object],Schiffl, H. et al. N Engl J Med 2002;346:305-310 P=0.01 P=0.001
odds ratio of death Schiffl, H. et al. N Engl J Med 2002;346:305-310 P=0.002 P=0.005 P=0.007 P=0.02
adding dialysis to CVVH ,[object Object],[object Object],[object Object],P=0.03 P=0.008 Saudin P, Niederberger S, De Seigneux S, Et al. Kidney Int 2006; 70: 1312-7.
Ronco    425  CVVH  20/h vs. 35-45 ml/kg/h* Bouman   106  CVVH  20ml/kg/h* vs. 48 ml/kg/h Schiffl   160  Alternate day vs. daily hemodialysis Saudan    206  CVVH 25 ml/kg/h vs. CVVHDF 42 ml/kg/h Total (fixed effects) Total (random effects) 1 10 Odds ratio Study    n   treatment groups *For purposes of analysis the two high-dose arms in Ronco were combined, as were the two low-dose arms in Bouman. If these groups are removed the odds ratio is unchanged (1.94;  P  <0.001). Kellum J. Nature Clin Practice Nephrol 2007 3: 128-9.
 
ATN trial ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
interventions
endpoint ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
results 563 enrolled in standard care 561 randomized to intensive therapy
[object Object],[object Object],[object Object],[object Object],[object Object]
 
 
This report currently should be viewed as   the definitive study   defining dialysis dosing  in critically ill patients with AKI H. David Hume
… the  patient dies  from   multi-organ failure  while in  exquisite  electrolyte &  fluid balance .
Fluid balance?
[object Object],[object Object],[object Object],X 100
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],More fluid. More sick.
Worse fluid overload severity remained independently associated with mortality (OR, 1.03; 95% CI, 1.01-1.05). The relationship was satisfactorily linear and the OR suggests a  3% increase  in mortality  for each  1% increase   in degree of fluid overload  at CRRT initiation.
[object Object],[object Object],[object Object],[object Object],[object Object]
[in regards to the kidney]  these excretory operations are incidental to the major task of keeping our internal environments in the  ideal, balanced state . Homer Smith from Fish to Philosopher
Medical therapy of acute kidney injury  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
furosemide ,[object Object],[object Object]
Mehta’s trial of furosemide in arf ,[object Object],[object Object],Mehta, R. L. et al. JAMA 2002;288:2547-2553.
furosemide the rct ,[object Object],[object Object],[object Object],[object Object],[object Object],Cantarovich F, Rangoonwala B, Et al. Am J Kidney Dis 2004; 44: 402-9.
dopamine: still doesn’t work ,[object Object],[object Object],Increased RBF Increased urine
dopamine: still doesn’t work ,[object Object],[object Object],[object Object],ANZICS Clinical Trials Group. Lancet 2000;356:2139-47. Kellum JA, Decker JM.Crit Care 2001; 29:1526-31.
dopamine: still doesn’t work ,[object Object],[object Object],[object Object],[object Object],ANZICS Clinical Trials Group. Lancet 2000;356:2139-47. Kellum JA, Decker JM.Crit Care 2001; 29:1526-31.
dopamine: the randomized controlled trial ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ANZICS Clinical Trials Group. Lancet 2000;356:2139-47.
[object Object],[object Object],[object Object],[object Object],[object Object]
meta-analysis ,[object Object],[object Object],Kellum JA, Decker JM.Crit Care 2001; 29:1526-31.
[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
complications of low-dose dopamine ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
dopamine 2.0: fenoldapam ,[object Object],[object Object],[object Object],[object Object],[object Object]
RCT of fenoldapam ,[object Object],[object Object],[object Object],[object Object],Tumlin JA, Finkel KW, Murray PT, Et al. Am J Kidney Dis. 2005; 46:26-34.
P=0.235 P=0.163 P=0.068 P=0.048 P=0.015 P=0.036 P=0.022 Tumlin JA, Finkel KW, Murray PT, Et al. Am J Kidney Dis. 2005; 46:26-34.
Tumlin JA, Finkel KW, Murray PT, Et al. Am J Kidney Dis. 2005; 46:26-34.
prophylactic fenoldapam in sepsis ,[object Object],[object Object],[object Object],[object Object]
Prophylaxis  is a way to get around the problem of late diagnosis due to the lack of an established biomarker.
P=0.006 P=0.056 Fenoldapam Placebo
atrial natriuretic peptide ,[object Object],[object Object],[object Object],[object Object]
radiocontrast nephropathy ,[object Object],[object Object],[object Object],[object Object],[object Object],Kurnik B, Allgren RL, Genter FC. Am J Kid Dis 1998; 31: 674-80.
[object Object],[object Object],[object Object],[object Object],Allgren R, Manbury T, Rahman SN. N Eng J Med 1997; 336: 828-34.  p =0.008
oliguric follow-up. strict EBM. ,[object Object],[object Object],Lewis J, Salem M, Chertow G. Am J Kid Dis 2000; 36: 767-74.  P=0.22 P=0.51 P<0.001
fixing everything that was wrong ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Swärd K, Valsson F, Odencrants P, Et al. Crit Care Med 2004; 32: 1310-5.
[object Object],[object Object],Swärd K, Valsson F, Odencrants P, Et al. Crit Care Med 2004; 32: 1310-5.
summary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
Done

Mais conteúdo relacionado

Mais procurados

Hepato encephalopathy
Hepato encephalopathyHepato encephalopathy
Hepato encephalopathy
Rs Naraa
 
TB or not TB: a diagnostic challenge
TB or not TB: a diagnostic challengeTB or not TB: a diagnostic challenge
TB or not TB: a diagnostic challenge
Samir Haffar
 
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
Ahmed Albeyaly
 

Mais procurados (20)

Hypertriglyceridemia Induced Pancreatitis
Hypertriglyceridemia Induced PancreatitisHypertriglyceridemia Induced Pancreatitis
Hypertriglyceridemia Induced Pancreatitis
 
A new perspective on hypokalemia
A new perspective on hypokalemiaA new perspective on hypokalemia
A new perspective on hypokalemia
 
Colorectal liver metastasis
Colorectal liver metastasisColorectal liver metastasis
Colorectal liver metastasis
 
Incremental Dialysis
Incremental DialysisIncremental Dialysis
Incremental Dialysis
 
Thyroid function test.pptx
Thyroid function test.pptxThyroid function test.pptx
Thyroid function test.pptx
 
Hepato encephalopathy
Hepato encephalopathyHepato encephalopathy
Hepato encephalopathy
 
NGAL in AKI
NGAL in AKINGAL in AKI
NGAL in AKI
 
portal bilioathy
portal bilioathyportal bilioathy
portal bilioathy
 
Primary sclerosing cholangitis.drquiyum
Primary sclerosing cholangitis.drquiyumPrimary sclerosing cholangitis.drquiyum
Primary sclerosing cholangitis.drquiyum
 
Acute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptxAcute-on-chronic liver failure (ACLF).pptx
Acute-on-chronic liver failure (ACLF).pptx
 
Liver function tests
Liver function tests Liver function tests
Liver function tests
 
Thyroid Functions
Thyroid FunctionsThyroid Functions
Thyroid Functions
 
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
Dysproteinemias Related Renal Disorders, Monoclonal Gammopathy (Paraproteinem...
 
TB or not TB: a diagnostic challenge
TB or not TB: a diagnostic challengeTB or not TB: a diagnostic challenge
TB or not TB: a diagnostic challenge
 
Hereditary pancreatitis
Hereditary pancreatitisHereditary pancreatitis
Hereditary pancreatitis
 
Kidney function tests
Kidney function testsKidney function tests
Kidney function tests
 
Meld scoring
Meld scoringMeld scoring
Meld scoring
 
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...case presentation Dr. Neveen Nabeeh >>>  14 Annunal Meeting of Nephrology Dep...
case presentation Dr. Neveen Nabeeh >>> 14 Annunal Meeting of Nephrology Dep...
 
Case presentation: Myesthenia Gravis and Lung cancer
Case presentation: Myesthenia Gravis and Lung cancerCase presentation: Myesthenia Gravis and Lung cancer
Case presentation: Myesthenia Gravis and Lung cancer
 
Thyroid function tests
Thyroid function testsThyroid function tests
Thyroid function tests
 

Destaque (6)

2 prismaflex crrt basic components - seg 2
2   prismaflex crrt basic components - seg 22   prismaflex crrt basic components - seg 2
2 prismaflex crrt basic components - seg 2
 
1 prismaflex crrt intro - seg 1 (2007)
1   prismaflex crrt intro - seg 1 (2007)1   prismaflex crrt intro - seg 1 (2007)
1 prismaflex crrt intro - seg 1 (2007)
 
CRRT workshop (Therapy overview I)
CRRT workshop (Therapy overview I)CRRT workshop (Therapy overview I)
CRRT workshop (Therapy overview I)
 
Kamc crrt training
Kamc crrt trainingKamc crrt training
Kamc crrt training
 
CRRT options in the ICU
CRRT options in the ICUCRRT options in the ICU
CRRT options in the ICU
 
3 prismaflex basic setup operation
3   prismaflex basic setup operation3   prismaflex basic setup operation
3 prismaflex basic setup operation
 

Semelhante a AKI Lecture 2010

02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
Dang Thanh Tuan
 
02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
guest2379201
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
Abhijit Nair
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
guest2379201
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
Dang Thanh Tuan
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
heyraghul
 
Acute Kidney Dysfunction
Acute Kidney DysfunctionAcute Kidney Dysfunction
Acute Kidney Dysfunction
Andrew Ferguson
 
What is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptxWhat is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptx
Dr.Jose Luis Rodriguez Lopez
 
21 Murphy Acute Renal Failure
21 Murphy   Acute Renal Failure21 Murphy   Acute Renal Failure
21 Murphy Acute Renal Failure
Dang Thanh Tuan
 
05 Goldstein Acute Renal Failure
05 Goldstein   Acute Renal Failure05 Goldstein   Acute Renal Failure
05 Goldstein Acute Renal Failure
guest2379201
 
How Best To Prevent & Manage Acute Renal failure
How Best To Prevent & Manage Acute Renal failureHow Best To Prevent & Manage Acute Renal failure
How Best To Prevent & Manage Acute Renal failure
chandra talur
 

Semelhante a AKI Lecture 2010 (20)

02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
 
02 Sperati Prevention And Management Of Acute Renal Failure
02 Sperati   Prevention And Management Of Acute Renal Failure02 Sperati   Prevention And Management Of Acute Renal Failure
02 Sperati Prevention And Management Of Acute Renal Failure
 
ARF No ATN Data
ARF No ATN DataARF No ATN Data
ARF No ATN Data
 
Acute kidney injury: Perioperative implications
Acute kidney injury: Perioperative implicationsAcute kidney injury: Perioperative implications
Acute kidney injury: Perioperative implications
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
 
29 amory renal failure
29 amory   renal failure29 amory   renal failure
29 amory renal failure
 
AKIforResidentsInternalMedicine2022.pptx
AKIforResidentsInternalMedicine2022.pptxAKIforResidentsInternalMedicine2022.pptx
AKIforResidentsInternalMedicine2022.pptx
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
 
09 Nouri Acute Renal Failure
09 Nouri   Acute Renal Failure09 Nouri   Acute Renal Failure
09 Nouri Acute Renal Failure
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Acute Kidney Dysfunction
Acute Kidney DysfunctionAcute Kidney Dysfunction
Acute Kidney Dysfunction
 
What is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptxWhat is teh nephrology power point presentation.pptx
What is teh nephrology power point presentation.pptx
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Renal Failure
Renal FailureRenal Failure
Renal Failure
 
21 Murphy Acute Renal Failure
21 Murphy   Acute Renal Failure21 Murphy   Acute Renal Failure
21 Murphy Acute Renal Failure
 
05 Goldstein Acute Renal Failure
05 Goldstein   Acute Renal Failure05 Goldstein   Acute Renal Failure
05 Goldstein Acute Renal Failure
 
Dr ahmed alkodousi case
Dr ahmed alkodousi   caseDr ahmed alkodousi   case
Dr ahmed alkodousi case
 
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coliHemolytic Uremic Syndrome: A Dangerous Complication of E. coli
Hemolytic Uremic Syndrome: A Dangerous Complication of E. coli
 
How Best To Prevent & Manage Acute Renal failure
How Best To Prevent & Manage Acute Renal failureHow Best To Prevent & Manage Acute Renal failure
How Best To Prevent & Manage Acute Renal failure
 
17 february lupus nephritis prof ashraf fouda
17 february lupus nephritis prof ashraf fouda17 february lupus nephritis prof ashraf fouda
17 february lupus nephritis prof ashraf fouda
 

Mais de Joel Topf

Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014
Joel Topf
 
Creatine supplements
Creatine supplementsCreatine supplements
Creatine supplements
Joel Topf
 
Imaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patientsImaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patients
Joel Topf
 
The Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney DiseaseThe Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney Disease
Joel Topf
 
Electrolyte Vignette
Electrolyte VignetteElectrolyte Vignette
Electrolyte Vignette
Joel Topf
 
The Kidney and HIV
The Kidney and HIVThe Kidney and HIV
The Kidney and HIV
Joel Topf
 

Mais de Joel Topf (20)

Hyperkalemia, an update
Hyperkalemia, an updateHyperkalemia, an update
Hyperkalemia, an update
 
Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
 
Low anion gap
Low anion gapLow anion gap
Low anion gap
 
Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014Herbal toxins grand rounds feb 2014
Herbal toxins grand rounds feb 2014
 
Acute Kidney Injury 2013
Acute Kidney Injury 2013Acute Kidney Injury 2013
Acute Kidney Injury 2013
 
Prescribing an app
Prescribing an appPrescribing an app
Prescribing an app
 
Creatine supplements
Creatine supplementsCreatine supplements
Creatine supplements
 
Social Media in Health Care
Social Media in Health CareSocial Media in Health Care
Social Media in Health Care
 
Imaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patientsImaging in Acute Kidney Injury, how not to harm patients
Imaging in Acute Kidney Injury, how not to harm patients
 
Uric Acid, Fructose and Hypertension
Uric Acid, Fructose and HypertensionUric Acid, Fructose and Hypertension
Uric Acid, Fructose and Hypertension
 
Hyponatremia
HyponatremiaHyponatremia
Hyponatremia
 
Diabetic Nephropathy 2009
Diabetic Nephropathy 2009Diabetic Nephropathy 2009
Diabetic Nephropathy 2009
 
Osmolar Gap
Osmolar GapOsmolar Gap
Osmolar Gap
 
Sodium dreadnaught
Sodium dreadnaughtSodium dreadnaught
Sodium dreadnaught
 
Electrolyte Free Water Clearance
Electrolyte Free Water ClearanceElectrolyte Free Water Clearance
Electrolyte Free Water Clearance
 
The Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney DiseaseThe Two Faces of Geriatric Kidney Disease
The Two Faces of Geriatric Kidney Disease
 
Whats New In Potassium
Whats New In PotassiumWhats New In Potassium
Whats New In Potassium
 
Lead Time Bias
Lead Time BiasLead Time Bias
Lead Time Bias
 
Electrolyte Vignette
Electrolyte VignetteElectrolyte Vignette
Electrolyte Vignette
 
The Kidney and HIV
The Kidney and HIVThe Kidney and HIV
The Kidney and HIV
 

Último

Poster_density_driven_with_fracture_MLMC.pdf
Poster_density_driven_with_fracture_MLMC.pdfPoster_density_driven_with_fracture_MLMC.pdf
Poster_density_driven_with_fracture_MLMC.pdf
Alexander Litvinenko
 
The basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptxThe basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptx
heathfieldcps1
 
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
中 央社
 
SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project research
CaitlinCummins3
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
中 央社
 

Último (20)

How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17How To Create Editable Tree View in Odoo 17
How To Create Editable Tree View in Odoo 17
 
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
Exploring Gemini AI and Integration with MuleSoft | MuleSoft Mysore Meetup #45
 
MOOD STABLIZERS DRUGS.pptx
MOOD     STABLIZERS           DRUGS.pptxMOOD     STABLIZERS           DRUGS.pptx
MOOD STABLIZERS DRUGS.pptx
 
Capitol Tech Univ Doctoral Presentation -May 2024
Capitol Tech Univ Doctoral Presentation -May 2024Capitol Tech Univ Doctoral Presentation -May 2024
Capitol Tech Univ Doctoral Presentation -May 2024
 
Improved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio AppImproved Approval Flow in Odoo 17 Studio App
Improved Approval Flow in Odoo 17 Studio App
 
Poster_density_driven_with_fracture_MLMC.pdf
Poster_density_driven_with_fracture_MLMC.pdfPoster_density_driven_with_fracture_MLMC.pdf
Poster_density_driven_with_fracture_MLMC.pdf
 
Benefits and Challenges of OER by Shweta Babel.pptx
Benefits and Challenges of OER by Shweta Babel.pptxBenefits and Challenges of OER by Shweta Babel.pptx
Benefits and Challenges of OER by Shweta Babel.pptx
 
philosophy and it's principles based on the life
philosophy and it's principles based on the lifephilosophy and it's principles based on the life
philosophy and it's principles based on the life
 
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading RoomSternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading Room
 
Implanted Devices - VP Shunts: EMGuidewire's Radiology Reading Room
Implanted Devices - VP Shunts: EMGuidewire's Radiology Reading RoomImplanted Devices - VP Shunts: EMGuidewire's Radiology Reading Room
Implanted Devices - VP Shunts: EMGuidewire's Radiology Reading Room
 
An overview of the various scriptures in Hinduism
An overview of the various scriptures in HinduismAn overview of the various scriptures in Hinduism
An overview of the various scriptures in Hinduism
 
II BIOSENSOR PRINCIPLE APPLICATIONS AND WORKING II
II BIOSENSOR PRINCIPLE APPLICATIONS AND WORKING IIII BIOSENSOR PRINCIPLE APPLICATIONS AND WORKING II
II BIOSENSOR PRINCIPLE APPLICATIONS AND WORKING II
 
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...
TỔNG HỢP HƠN 100 ĐỀ THI THỬ TỐT NGHIỆP THPT VẬT LÝ 2024 - TỪ CÁC TRƯỜNG, TRƯ...
 
24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...
24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...
24 ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH SỞ GIÁO DỤC HẢI DƯ...
 
The basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptxThe basics of sentences session 4pptx.pptx
The basics of sentences session 4pptx.pptx
 
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文會考英文
 
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
ĐỀ THAM KHẢO KÌ THI TUYỂN SINH VÀO LỚP 10 MÔN TIẾNG ANH FORM 50 CÂU TRẮC NGHI...
 
SURVEY I created for uni project research
SURVEY I created for uni project researchSURVEY I created for uni project research
SURVEY I created for uni project research
 
Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...
Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...
Basic Civil Engineering notes on Transportation Engineering, Modes of Transpo...
 
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽會考英聽
 

AKI Lecture 2010

  • 1. acute renal failure … from basics to the latest advances Joel M. Topf, MD Clinical Nephrologist http://pbfluids.com
  • 3. Dr. Haas invented the first dialysis machine designed for humans and in 1928 he treated 6 patients. All of them died.
  • 4. In 1943, Willem Kolff’s, working in Nazi occupied Netherlands created the second human dialysis machine. In 1943 he dialyzed his first patient, a young man with acute nephritis. In 1945, a 67-year-old woman in uremic coma presented to Dr Kolff.                 Regained consciousness after 11 hours of hemodialysis.       Dr. Haas
  • 5.
  • 6.  
  • 7.  
  • 8.
  • 9.
  • 10. Same rise in creatinine. Same diagnosis: acute renal failure. Two completely different diseases. Two women. Same age. Same race.
  • 11.
  • 12.
  • 13.
  • 14.  
  • 15.  
  • 16. R isk I njury F ailure L oss of function E nd-Stage Renal disease rifle criteria for stratifying arf
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22. R isk : Inc Cr 50-100% or U.O. < 0.5 mL/kg/hr for > 6 hrs I njury : Inc Cr 100-200% or U.O. < 0.5 mL/kg/hr > 12 hrs F ailure : Inc Cr > 200% or > 4 mg/dL or U.O. < 0.3 mL/kg/hr > 24 hrs or anuria for more than 12 hours L oss of function : Need for dialysis for more than 4 weeks E nd-Stage Renal disease : Need for dialysis for more than 3 months
  • 23.
  • 24. Hospital Mortality >3x BL Cr Cr > 4
  • 25.
  • 26.  
  • 27. when Hoste looked at markers of severity of illness excluding the renal system: No survival difference between the 4 groups: • Lack of renal failure • Risk • Injury • Failure
  • 28. RIFLE is dependent on creatinine. creatine is a functional marker of organ damage Functional markers: old and busted
  • 29. biomarkers are foot prints of actual organ damage Biomarkers, new hotness
  • 30. functional versus biomarkers Functional Marker Biomarker Liver damage Hypoalbuminemia Coagulopathy SGOT SGPT GGT
  • 31. functional versus biomarkers Functional Marker Biomarker Liver damage Hypoalbuminemia Coagulopathy SGOT SGPT GGT Heart damage Hypotension Arrhythmia Troponin I Troponin T CK-MB
  • 32. functional versus biomarkers Functional Marker Biomarker Liver damage Hypoalbuminemia Coagulopathy SGOT SGPT GGT Heart damage Hypotension Arrhythmia Troponin I Troponin T CK-MB Kidney damage Creatinine BUN Cystatin C KIM-1 NGAL
  • 33.
  • 34. <0.5 0.4 0.2 0.1 0.3 0.5 0.7 0.9 Creatinine falls Creatinine rises Delta Creatinine (mg/dL)
  • 35. candidates for a renal troponin:
  • 36.
  • 37.
  • 38.
  • 39.  
  • 40.  
  • 41.  
  • 43.
  • 44. Hou SH, Bushinsky DA, Wish JB. Am J Med 1983; 74: 243-8. Nash K, Hafeez A, Hou S. Am J Kidney Dis. 2002; 39: 930-6. Kaufman J, Dhakal M, Patel B, Et al. Am J Kidney Dis 1991; 17: 191-8.
  • 45. Hou SH, Bushinsky DA, Wish JB. Am J Med 1983; 74: 243-8. Nash K, Hafeez A, Hou S. Am J Kidney Dis. 2002; 39: 930-6. Kaufman J, Dhakal M, Patel B, Et al. Am J Kidney Dis 1991; 17: 191-8.
  • 46. N=103 N=256 N=389 Pascual J, Liano F. J Am Geriatr Soc 1998, 46: 1-5.
  • 47. hospital acquired acute renal failure
  • 48. hospital acquired acute renal failure
  • 49.  
  • 50.  
  • 51. Pre-renal azotemia No BP, no pee pee
  • 52.
  • 53.
  • 54.  
  • 55. Excreted Na Filtered Na Fractional excretion of sodium:
  • 56. Excreted Na = Urine Na x Urine Volume Calculating the Numerator
  • 57. Filtered Na = Serum Na x GFR Calculating the Denominator GFR = Urine Cr x Urine Volume Serum Cr Filtered Na = Serum Na x UrCr x UrVol Serum Cr
  • 58. Urine Na x Urine Volume Serum Na x UrCr x Urine Volume Serum Cr FENa = Excreted Na Filtered Na FENa = Urine Na Serum Na x UrCr Serum Cr FENa = Urine Na x Serum Cr Serum Na x UrCr FENa =
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65.  
  • 66.  
  • 67.
  • 69. therapy Renal replacement therapy Furosemide Dopamine Fenoldapam hANP (Anaritide)
  • 71. Dialysate Conventional Dialysis Diffusive Clearance 136 5.8 108 17 67 3.8 145 2 110 35 0 0
  • 72. 80 mmol K 5.8 mmol/L = 13.8 liters Isolated Ultrafiltration: CHF Solutions Minimal clearance 136 5.8 108 17 67 3.8 136 5.8 108 17 67 3.8
  • 73. Ultrafilter 3+ liters/hour Replace all ultrafiltrate with sterile fluid at ideal plasma concentrations CVVH Convective clearance 136 5.8 108 17 67 3.8 140 2 108 30 0 0 140 4 108 30 0 0
  • 74. Post-filter replacement fluid CVVH Convective clearance
  • 75. Pre-filter replacement fluid CVVH Convective clearance
  • 77. high dose dialysis survival Severity of illness (CCARF Score) High dose Low dose
  • 78.
  • 79. 20 mL/kg/hr 35 mL/kg/hr 45 mL/kg/hr Ronco C, Bellomo R, Hormea P, Et al. Lancet 2000; 355: 26-30.
  • 80.
  • 81. odds ratio of death Schiffl, H. et al. N Engl J Med 2002;346:305-310 P=0.002 P=0.005 P=0.007 P=0.02
  • 82.
  • 83. Ronco 425 CVVH 20/h vs. 35-45 ml/kg/h* Bouman 106 CVVH 20ml/kg/h* vs. 48 ml/kg/h Schiffl 160 Alternate day vs. daily hemodialysis Saudan 206 CVVH 25 ml/kg/h vs. CVVHDF 42 ml/kg/h Total (fixed effects) Total (random effects) 1 10 Odds ratio Study n treatment groups *For purposes of analysis the two high-dose arms in Ronco were combined, as were the two low-dose arms in Bouman. If these groups are removed the odds ratio is unchanged (1.94; P <0.001). Kellum J. Nature Clin Practice Nephrol 2007 3: 128-9.
  • 84.  
  • 85.
  • 87.
  • 88. results 563 enrolled in standard care 561 randomized to intensive therapy
  • 89.
  • 90.  
  • 91.  
  • 92. This report currently should be viewed as the definitive study defining dialysis dosing in critically ill patients with AKI H. David Hume
  • 93. … the patient dies from multi-organ failure while in exquisite electrolyte & fluid balance .
  • 95.
  • 96.
  • 97. Worse fluid overload severity remained independently associated with mortality (OR, 1.03; 95% CI, 1.01-1.05). The relationship was satisfactorily linear and the OR suggests a 3% increase in mortality for each 1% increase in degree of fluid overload at CRRT initiation.
  • 98.
  • 99. [in regards to the kidney] these excretory operations are incidental to the major task of keeping our internal environments in the ideal, balanced state . Homer Smith from Fish to Philosopher
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105.
  • 106.
  • 107.
  • 108.
  • 109.
  • 110.
  • 111.
  • 112.
  • 113.
  • 114.
  • 115. P=0.235 P=0.163 P=0.068 P=0.048 P=0.015 P=0.036 P=0.022 Tumlin JA, Finkel KW, Murray PT, Et al. Am J Kidney Dis. 2005; 46:26-34.
  • 116. Tumlin JA, Finkel KW, Murray PT, Et al. Am J Kidney Dis. 2005; 46:26-34.
  • 117.
  • 118. Prophylaxis is a way to get around the problem of late diagnosis due to the lack of an established biomarker.
  • 120.
  • 121.
  • 122.
  • 123.
  • 124.
  • 125.
  • 126.
  • 127.
  • 128. Done

Notas do Editor

  1. Talk about the difficulty of using medline to differentiate the two conditions, imagine the difficulty of studying these patients in a trial for treatment for ARF Nephrology needed a language to describe ARF Similar to CKD where some people used the term CRI to describe a pt with a cr of 1.7 and other described a patient with a cr of 4.5 about to start dialysis
  2. An example of the former is contrast nephropathy where an event is defined by a 0.5 mg/dL or 25% increase in serum creatinine. The use of RRT to define ARF is often used in retrospective cohorts because it is easily gleaned from procedure codes and is unambiguous as well as unanimously perceived as an important end-point.
  3. An example of the former is contrast nephropathy where an event is defined by a 0.5 mg/dL or 25% increase in serum creatinine. The use of RRT to define ARF is often used in retrospective cohorts because it is easily gleaned from procedure codes and is unambiguous as well as unanimously perceived as an important end-point.
  4. An example of the former is contrast nephropathy where an event is defined by a 0.5 mg/dL or 25% increase in serum creatinine. The use of RRT to define ARF is often used in retrospective cohorts because it is easily gleaned from procedure codes and is unambiguous as well as unanimously perceived as an important end-point.
  5. Acute dialysis quality initiative (ADQI) Acute dialysis quality initiative (ADQI) Group of interested intensivists, nephrologists and industry representatives charged with publishing evidence based clinical practice guidelines Created a consensus definition of acute renal failure
  6. Acute dialysis quality initiative (ADQI)
  7. Acute dialysis quality initiative (ADQI)
  8. Acute dialysis quality initiative (ADQI)
  9. Acute dialysis quality initiative (ADQI)
  10. Acute dialysis quality initiative (ADQI)
  11. Acute dialysis quality initiative (ADQI)
  12. Acute dialysis quality initiative (ADQI)
  13. Suggesting the difference in mortality is accounted solely by the increasing severity of renal failure
  14. Paganini at Cleveland clinic retrospectively looked at dose of dialysis during ARF and compared it to survival stratified by Predicted mortality
  15. Primary outcome to
  16. Primary outcome to